12 unknown. 12 Phase 2, 6 Phase 3, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Unknown 12 |
| Phase 3 | 6 | Unknown 6 |
| Phase 1 | 3 | Unknown 3 |
Follow Lucentis: new trials by email Literature Review of Lucentis trials Research Report on Lucentis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of MW02 in the Treatment of nAMD MW02, Lucentis - Wet Age-related Macular Degeneration | Phase 2 / Phase 3 | Unknown | Mabwell (Shanghai) Bioscience Co., Ltd. | 433 | 2021-05-07 | 2022-03-28 |
| Analysis of Aqueous and Vitreous Humor Ranibizumab, No Ranibizumab - Proliferative Diabetic Retinopathy, Macular Degeneration | Phase 2 | Unknown | California Retina Consultants | 45 | 2015-07-01 | 2017-03-01 |
| 25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China Ranibizumab, Triamcinolone Acetonide - Proliferative Diabetic Retinopathy | Phase 2 / Phase 3 | Unknown | JUNYAN ZHANG | 120 | 2015-02-01 | 2016-08-25 |
| Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients Ranibizumab, Bevacizumab, Aflibercept - Age Related Macular Degeneration | Phase 2 / Phase 3 | Unknown | East Florida Eye Institute | 80 | 2014-12-01 | 2015-08-11 |
| Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab Ranibizumab 0.3mg/0.05cc - Diabetic Macular Edema | Phase 1 / Phase 2 | Unknown | Southeast Retina Center, Georgia | 30 | 2013-04-01 | 2014-09-17 |
| Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO) Bevacizumab, Ranibizumab - Retinal Vein Occlusion | Phase 2 / Phase 3 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 296 | 2012-06-01 | 2015-07-01 |
| Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME) Ranibizumab, Bevacizumab - Diabetic Macular Edema | Phase 2 / Phase 3 | Unknown | Prof. dr. R.O. Schlingemann | 246 | 2012-06-01 | 2015-07-01 |
| Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab Ranibizumab, Triamcinolone Acetonide - Wet Macular Degeneration | Phase 2 | Unknown | University Health Network, Toronto | 30 | 2011-01-01 | 2011-02-09 |
| Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular Edema Bevacizumab, Ranibizumab - Diabetic Retinopathy, Macular Edema | Phase 2 | Unknown | University of Sao Paulo | 53 | 2010-04-01 | 2011-12-13 |
| Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome ranibizumab - Ocular Histoplasmosis Syndrome | Phase 1 / Phase 2 | Unknown | Retina Associates of Kentucky | 20 | 2009-08-01 | 2009-08-10 |
| Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study) Intravitreal injection of ranibizumab - Proliferative Diabetic Retinopathy | Phase 1 / Phase 2 | Unknown | University of Sao Paulo | 22 | 2008-09-01 | 2009-10-12 |
| Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME) Ranibizumab - Diabetic Macular Edema | Phase 2 / Phase 3 | Unknown | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | 40 | 2008-05-01 | 2011-06-27 |
Macular Degeneration (3) · Diabetic Retinopathy (2) · Macular Edema (2) · Glaucoma, Neovascular (1) · Histoplasmosis (1) · Retinal Perforations (1) · Retinal Vein Occlusion (1) · Vision Disorders (1) · Wet Macular Degeneration (1)
University of Sao Paulo (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · California Retina Consultants (1) · East Florida Eye Institute (1) · JUNYAN ZHANG (1) · Mabwell (Shanghai) Bioscience Co., Ltd. (1) · Prof. dr. R.O. Schlingemann (1) · Retina Associates of Kentucky (1) · Southeast Retina Center, Georgia (1) · The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery (1) · University Health Network, Toronto (1)
United States (4) · China (2) · Netherlands (2) · Austria (1) · Brazil (1) · Canada (1)
Reinier O Schlingemann, MD, PhD (2) · Dennis M Marcus, M.D. (1) · Felipe Almeida, MD (1) · John Kitchens, MD (1) · Robert L Avery, MD (1) · Rodrigo Jorge, MD (1) · Rodrigo Jorge, MD, PhD (1) · Ronald E Frenkel, MD (1) · Ulrike Stolba, MD (1) · Wai-Ching Lam, MD, FRCSC (1)